GARD®air.

A predictive test for chemical respiratory sensitizers

GARDair is an in vitro test capable of identifying chemical respiratory sensitizers. The test provides a binary prediction, classifying the test samples as either respiratory sensitizers or non-sensitizers.

With a high specificity of 95%, GARDair is recommended for use as an R&D tool to identify and rule out respiratory sensitizers in candidate ingredients. The high specificity means that there are few false positive results (5%). If a sample is classified as a respiratory sensitizer in GARDair, you can trust the result and remove the candidate ingredient with confidence. Furthermore, unnecessary measures on falsely classified sensitizers can be avoided.

GARDair is the only available test for respiratory sensitization on the market.

For R&D purposes

GARDair is recommended for use as an R&D tool to identify and rule out respiratory sensitizers in candidate ingredients.
28 genes

The number of biomarkers used in GARDair.